Fungal Disease

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Scynexis
ScynexisJERSEY CITY, NJ
1 program
1
IbrexafungerpPhase 11 trial
Active Trials
NCT05668429CompletedEst. Jan 2023

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
ScynexisIbrexafungerp

Clinical Trials (1)

NCT05668429ScynexisIbrexafungerp

ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects

Start: Dec 2022Est. completion: Jan 2023
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space